Panacea Biotec

We would like to inform you that the Company has received on 01.03.2026, a Demand Order dated 27.02.2026, from the Office of Deputy Commissioner of...

02 Mar, 2026 | 12:41pm • Source: BSE

Please find enclosed herewith newspaper copies of the Extract of Statement of Unaudited Financial Results for quarter and nine months ended 31.12.2025.

12 Feb, 2026 | 03:50pm • Source: BSE

Please find enclosed details of shares dematerialised during January 2026 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018

06 Feb, 2026 | 03:32pm • Source: BSE

Please find attached outcome of inspection by National Centre for Public Health and Pharmacy, Hungary at manufacturing facility of the Company''s material wholly owned subsidiary,...

05 Feb, 2026 | 02:52pm • Source: BSE

Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and...

02 Feb, 2026 | 03:42pm • Source: BSE

We are now delighted to inform you that enrolment of study participants in context of DengiAll Phase-III clinical trial has been completed.

07 Jan, 2026 | 06:36pm • Source: BSE

Please find enclosed certificate dated January 02, 2026, issued by Skyline Financial Services Pvt. Ltd. , Registrar and Transfer Agent of the Company, confirming compliance...

07 Jan, 2026 | 04:49pm • Source: BSE

Please find the details of shares dematerialised during December 2025 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018

07 Jan, 2026 | 04:45pm • Source: BSE

Please find attached disclosure regarding receipt of Demand Orders under Section 156 of the Income Tax Act.

26 Dec, 2025 | 06:10pm • Source: BSE

We would like to inform you that the trading window of the Company shall remain closed for all Designated Persons (including their immediate relatives) of...

26 Dec, 2025 | 05:54pm • Source: BSE

We are delighted to inform you about the receipt of an amended Award from UNICEF for supply of Pentavalent vaccine, Easyfive-TT

24 Dec, 2025 | 05:09pm • Source: BSE

We would like to inform you that the Board of Directors in its meeting held today i.e. December 15, 2025, approved revised Policy for determining...

15 Dec, 2025 | 06:54pm • Source: BSE

We would like to inform you that Mr. Ankit Jain (who is currently acting as Assistant General Manager - Legal of the Company''s wholly owned...

15 Dec, 2025 | 06:43pm • Source: BSE

We would like to inform you that Mr. Vinod Goel (who is currently acting as Group CFO and Head Legal & Company Secretary as well...

15 Dec, 2025 | 06:38pm • Source: BSE

Mr. Vinod Goel (who is currently acting as Group CFO and Head Legal & Company Secretary as well as Compliance Officer of the Company) has...

15 Dec, 2025 | 06:34pm • Source: BSE

Please enclosed herewith the details of shares dematerialised during November 2025

04 Dec, 2025 | 03:11pm • Source: BSE

Please find enclosed herewith the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2025. The...

14 Nov, 2025 | 05:24pm • Source: BSE

We would like to inform you that the Board of Directors has at its meeting held today, i.e. November14, 2025, inter-alia, considered and approved the...

14 Nov, 2025 | 05:17pm • Source: BSE

We are delighted to inform you that the Company has received an Award notification from PAHO under a Long-Term Agreement for supply of Easyfive-TT to...

11 Nov, 2025 | 04:56pm • Source: BSE

Please find attached details of shares dematerialised during October 2025.

07 Nov, 2025 | 05:48pm • Source: BSE